利凡诺瓦
LIVN
77.58
-0.92
-1.17%
利凡诺瓦
US · LIVN
#2263 按市值排名
上市于 1970
77.58
-0.92
-1.17%
实时 - 追踪5344个代码 - 心跳于383秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了2家。
- 机构持股总比例下降了0.1个百分点。
机构持股
- 机构持股比例
- 114.78% -0.11pp
- 机构数量
- 374 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund95.55%
Hedge Fund10.30%
Public Company4.48%
Government Pension Fund1.90%
Insurance Company1.47%
Private Company0.47%
Individual/Insider0.44%
Sovereign Wealth Fund0.31%
Family Office/Trust0.17%
主要股东 截至 2026-06-30
BlackRock
13.73% · 7.57M 股
PRIMECAP Management Company
7.57% · 4.17M 股
FMR
5.71% · 3.15M 股
Hood River Capital Management LLC
4.66% · 2.57M 股
AQR Capital Management
4.25% · 2.34M 股
Artisan Partners Limited Partnership
4.04% · 2.22M 股
State Street Global Advisors
3.93% · 2.17M 股
American Century Investment Management
3.66% · 2.01M 股
Dimensional Fund Advisors
3.35% · 1.85M 股
Geode Capital Management, LLC
3.19% · 1.76M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 30次买入 · 19次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Alex Shvartsburg | Chief Financial Officer | 0.08% |
| William Kozy | Chairman of Board & Interim CEO | 0.07% |
| Stephanie Bolton | President of Global Epilepsy | 0.04% |
| Trui Hebbelinck | Chief Human Resources Officer | 0.03% |
| Stacy Seng | Independent Non-Executive Director | 0.03% |
| Vladimir Makatsaria | Chief Executive Officer | 0.03% |
| Todd Schermerhorn | Independent Non-Executive Director | 0.02% |
| Sharon O'Kane | Independent Non-Executive Director | 0.02% |
| Franco Poletti | President of Cardiopulmonary Business Unit | 0.02% |
| Peter Wilver | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-14 | Anne Liddy | Chief Legal Officer | Other Derivative Acquisition | +6,291 | -- |
| 2026-09-09 | Francesco Bianchi | Independent Non-Executive Director | Open Market Disposition | -3,500 | $78.01 |
| 2026-09-03 | Brooke Story | Independent Director | Open Market Disposition | -2,300 | $81.42 |
| 2026-09-01 | Franco Poletti | President of Cardiopulmonary Business Unit | Intent to Sell (Form 144) | -10,755 | $82.09 |
| 2026-08-30 | Francesco Bianchi | Independent Non-Executive Director | Open Market Disposition | -1,650 | $79.72 |
| 2026-08-10 | Ahmet Tezel | Chief Innovation Officer | Derivative Exercise and Sale | -12,692 | $52.68–77.86 |
| 2026-06-14 | Todd Schermerhorn | Independent Non-Executive Director | Derivative Exercise and Sale | -486 | $79.70 |
| 2026-06-14 | Todd Schermerhorn | Independent Non-Executive Director | Other Derivative Acquisition | +2,383 | -- |
| 2026-06-14 | Todd Schermerhorn | Independent Non-Executive Director | Derivative Exercise and Retained | +3,556 | -- |
| 2026-06-14 | Peter Wilver | Independent Director | Derivative Exercise and Sale | -486 | $79.70 |
| 2026-06-14 | Peter Wilver | Independent Director | Other Derivative Acquisition | +2,383 | -- |
| 2026-06-14 | Peter Wilver | Independent Director | Derivative Exercise and Retained | +3,556 | -- |
| 2026-06-14 | William Kozy | Chairman of Board & Interim CEO | Derivative Exercise and Sale | -682 | $79.70 |
| 2026-06-14 | William Kozy | Chairman of Board & Interim CEO | Other Derivative Acquisition | +2,383 | -- |
| 2026-06-14 | William Kozy | Chairman of Board & Interim CEO | Derivative Exercise and Retained | +4,999 | -- |
| 2026-06-14 | Stacy Seng | Independent Non-Executive Director | Derivative Exercise and Sale | -486 | $79.70 |
| 2026-06-14 | Stacy Seng | Independent Non-Executive Director | Other Derivative Acquisition | +2,383 | -- |
| 2026-06-14 | Stacy Seng | Independent Non-Executive Director | Derivative Exercise and Retained | +3,556 | -- |
| 2026-06-14 | Donald Zurbay | Director | Derivative Exercise and Sale | -308 | $79.70 |
| 2026-06-14 | Donald Zurbay | Director | Other Derivative Acquisition | +2,383 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
利凡诺瓦 讨论区 0 条评论